Why the study?
Does warfarin therapy induce defibrination in patients with protein C deficiency upon heparin discontinuation?
Does warfarin therapy induce defibrination in patients with protein C deficiency upon heparin discontinuation?
Warfarin therapy can exacerbate intravascular coagulation and lead to defibrination in patients with protein C deficiency when heparin is discontinued.
Answers are grounded in this paper and cite their sources.
May signal bleeding risk on heparin cessation in protein C deficiency; leaves open whether warfarin induces defibrination generally.
A 57 year old man presented with apparently spontaneous lower extremity deep vein thrombosis and pulmonary embolism. He was treated in conventional fashion with intravenous heparin and oral warfarin. After 4 daily doses of warfarin the prothrombin and proconvertin (P+P) time was within therapeutic range, and heparin was stopped. Over the next six hours complete defibrination occurred, associated with severe bleeding complications. Functional protein C measured after normalization of routine coagulation tests averaged 40% of normal, and was only 3.5% of normal immediately prior to the episode of defibrination. We conclude that the very low functional protein C levels seen immediately prior to defibrination were caused by a combination of pre-existent protein C deficiency and warfarin therapy, and directly predisposed to defibrination once heparin was stopped, despite "therapeutic" warfarin anticoagulation. Exacerbation of intravascular coagulation should be considered a potential prothrombotic effect of warfarin therapy in protein C deficient individuals.
No takes yet. Share an insight, caveat, or question.
Francis et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: